Literature DB >> 23639644

Surgical considerations in the treatment of gastric cancer.

Andrew M Blakely1, Thomas J Miner.   

Abstract

Gastric cancer is one of the most common malignancies in the world and is a leading cause of cancer death. Surgical treatment remains the best treatment option for potential cure and can be beneficial in the palliation of advanced disease. Several neoadjuvant chemotherapy regimens have been recently evaluated as potential adjuncts to surgery. This review describes the current role of surgical therapy in staging, resection, and palliation of gastric cancer.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23639644      PMCID： PMC4467541          DOI： 10.1016/j.gtc.2013.01.010

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN： 0889-8553            Impact factor:   3.806


  66 in total

1.  The difficult choice between total and proximal gastrectomy in proximal early gastric cancer.

Authors:  Ji Yeong An; Ho Geun Youn; Min Gew Choi; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  Am J Surg       Date:  2008-06-02       Impact factor: 2.565

2.  Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer.

Authors:  M Degiuli; M Sasako; A Ponti
Journal:  Br J Surg       Date:  2010-05       Impact factor: 6.939

3.  Influence of a microscopic positive proximal margin in the treatment of gastric adenocarcinoma of the cardia.

Authors:  Jian-Guo Shen; Jae-Ho Cheong; Woo-Jin Hyung; Junuk Kim; Seung-Ho Choi; Sung-Hoon Noh
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

4.  Palliative resection in noncurative gastric cancer patients.

Authors:  Kuo-Hung Huang; Chew-Wun Wu; Wen-Liang Fang; Jen-Hao Chen; Su-Shun Lo; Ruei-Fang Wang; Anna Fen-Yau Li
Journal:  World J Surg       Date:  2010-05       Impact factor: 3.352

5.  Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer.

Authors:  W Yu; G S Choi; H Y Chung
Journal:  Br J Surg       Date:  2006-05       Impact factor: 6.939

6.  Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial.

Authors:  Suzanne M Jeurnink; Ewout W Steyerberg; Jeanin E van Hooft; Casper H J van Eijck; Matthijs P Schwartz; Frank P Vleggaar; Ernst J Kuipers; Peter D Siersema
Journal:  Gastrointest Endosc       Date:  2009-12-08       Impact factor: 9.427

7.  Prognostic significance of microscopic positive margins for gastric cancer patients with potentially curative resection.

Authors:  Zhe Sun; De-ming Li; Zhen-ning Wang; Bao-jun Huang; Yan Xu; Kai Li; Hui-mian Xu
Journal:  Ann Surg Oncol       Date:  2009-07-22       Impact factor: 5.344

8.  Endoscopic ultrasound can improve the selection for laparoscopy in patients with localized gastric cancer.

Authors:  Derek G Power; Mark A Schattner; Hans Gerdes; Baruch Brenner; Arnold J Markowitz; Marinela Capanu; Daniel G Coit; Murray Brennan; David P Kelsen; Manish A Shah
Journal:  J Am Coll Surg       Date:  2008-12-18       Impact factor: 6.113

9.  Phase II study of neoadjuvant chemotherapy and extended surgery for locally advanced gastric cancer.

Authors:  T Yoshikawa; M Sasako; S Yamamoto; T Sano; H Imamura; K Fujitani; H Oshita; S Ito; Y Kawashima; N Fukushima
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

10.  Totally laparoscopic radical BII gastrectomy for the treatment of gastric cancer: a comparison with open surgery.

Authors:  Wei-Jei Lee; Weu Wang; Tai-Chi Chen; Jung-Chieh Chen; Kong-Han Ser
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2008-08       Impact factor: 1.719
View more
  11 in total

1.  Human Epidermal Growth Factor Receptor-2 in Sri Lankan Gastric Carcinoma Patients with Clinicopathological Association and Survival.

Authors:  Duminda Subasinghe; Sivasuriya Sivaganesh; Ananthi Samarsekera; Mariyan Priyanthi Kumarasinghe; Dharmabandhu Nandadeva Samarasekera; Menaka Dilani Samarwickrema Lokuhetty
Journal:  Dig Dis Sci       Date:  2017-06-13       Impact factor: 3.199

Review 2.  Surgical palliation of gastric outlet obstruction in advanced malignancy.

Authors:  Brittany A Potz; Thomas J Miner
Journal:  World J Gastrointest Surg       Date:  2016-08-27

3.  Laparoscopic resection of synchronous gastric cancer and primary small intestinal lymphoma: a case report.

Authors:  Ding-Wei Chen; Yu Pan; Jia-Fei Yan; Yi-Ping Mou
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 4.  Current Perspectives on Gastric Cancer.

Authors:  Juan M Marqués-Lespier; María González-Pons; Marcia Cruz-Correa
Journal:  Gastroenterol Clin North Am       Date:  2016-09       Impact factor: 3.806

5.  Hydroferrate fluid, MRN-100, provides protection against chemical-induced gastric and esophageal cancer in Wistar rats.

Authors:  Mamdooh H Ghoneum; Nariman K Badr El-Din; Salma M Abdel Fattah; Deyu Pan; Lucilene Tolentino
Journal:  Int J Biol Sci       Date:  2015-01-28       Impact factor: 6.580

6.  Multidetector computed tomography in the preoperative staging of gastric adenocarcinoma.

Authors:  Ricardo Hoelz de Oliveira Barros; Thiago José Penachim; Daniel Lahan Martins; Nelson Adami Andreollo; Nelson Marcio Gomes Caserta
Journal:  Radiol Bras       Date:  2015 Mar-Apr

7.  Outcomes of Laparoscopic Total Gastrectomy for Elderly Gastric Cancer Patients.

Authors:  Shihou Sheng; Yahong Chen; Chunsheng Li
Journal:  J Cancer       Date:  2018-10-22       Impact factor: 4.207

8.  Palliative Gastrectomy and Survival in Patients With Metastatic Gastric Cancer: A Propensity Score-Matched Analysis of a Large Population-Based Study.

Authors:  Qin Li; Jiahua Zou; Mingfang Jia; Ping Li; Rui Zhang; Jianglong Han; Kejie Huang; Yunfeng Qiao; Tangpeng Xu; Ruan Peng; Qibin Song; Zhenming Fu
Journal:  Clin Transl Gastroenterol       Date:  2019-05-22       Impact factor: 4.488

9.  Variable copy number of mitochondrial DNA (mtDNA) predicts worse prognosis in advanced gastric cancer patients.

Authors:  Guanjun Zhang; Yiping Qu; Siwen Dang; Qi Yang; Bingyin Shi; Peng Hou
Journal:  Diagn Pathol       Date:  2013-10-21       Impact factor: 2.644

10.  Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute.

Authors:  Li-Bo Sun; Guo-Jie Zhao; Da-Yong Ding; Bin Song; Rui-Zhi Hou; Yong-Chao Li
Journal:  World J Surg Oncol       Date:  2014-09-08       Impact factor: 2.754
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.